Diabetes mellitus and pre-diabetes mellitus are associated with lower body mass indices and increased risk of cardiovascular events (including heart failure) at lower glucose thresholds in Chinese compared with Western cohorts. However, the extent of cardiac remodeling and regulation on cardiac mechanics in lean and nonlean dysglycemic Chinese adults is understudied.
D
iabetes mellitus is a global health problem, with China leading with the largest current and projected diabetic population in the world, estimated at 98.4 million in 2013, growing to 142.7 million by 2035. 1 Diabetes mellitus is known to be an independent risk factor for heart failure (HF), 2, 3 and a diabetic cardiomyopathy characterized by left ventricular (LV) hypertrophy, fibrosis, and dysfunction has been well described. 4, 5 Recent data show that the risk for cardiac dysfunction 6 and cardiovascular events 7 extend to the prediabetic range of dysglycemia. In Chinese populations, the threshold of dysglycemia associated with increased risk of cardiovascular events may be even lower 8 ; however, the impact of dysglycemia across the entire glycemic spectrum on cardiac structure and function has not been studied in large populations of Chinese.
Furthermore, compared with European patients, diabetes mellitus develops in Chinese at a younger age and lower body mass index (BMI)-the so-called lean diabetic phenotype. 9, 10 Obesity per se is also associated with obesity cardiomyopathy, which may be difficult to distinguish from the pure effects of diabetes mellitus in Western cohorts where both risk factors frequently coexist. 11 We aimed to study the relationship between dysglycemia and cardiac structure and function across the glycemic spectrum in a large asymptomatic Chinese population. We hypothesized that preclinical cardiac structural or functional abnormalities may be identified at an early stage in the dysglycemia continuum among Chinese. We further sought to determine the threshold of various dysglycemic indices at which cardiac abnormalities may be found and whether these associations differed between lean and nonlean individuals.
METHODS

Study Population and Patient Selection Criteria
Our study population consisted of consecutive participants in an ongoing cardiovascular health screening program from June 2009 to December 2012 at MacKay Memorial Hospital, a tertiary medical center in Northern Taipei, Taiwan. The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure by MacKay Memorial Hospital Institutional Data Access. All 3950 participants underwent detailed physical examination, baseline anthropometric measurements, biochemical studies, and comprehensive echocardiography. The study setting and design is cross-sectional and had been described in previous publication. [12] [13] [14] Participants with history of HF, coronary heart disease, myocardial infarction, cardiac pacemaker or defibrillator in place, or valvular heart disease were excluded. The study protocol was approved by an institutional review committee (14MMHIS202), and the study was approved with waiver of individual informed consent given the minimal risk as purely observational based on deidentified data only. Study procedures were conducted in accordance with institutional guidelines on the protection of human subjects.
Anthropometric Measurements
Clinical characteristics and anthropometric measures were comprehensively collected at baseline, including age, height, weight, waist circumference, and blood pressure. BMI was calculated as weight (kg) divided by the square of the body height (m). To measure the waist circumference (in centimeters), the waist-tape was placed horizontally around the midpoint between the lower rib margin and the iliac crest. We further defined lean BMI as <23 kg/m . 10 Standardized cuff
CLINICAL PERSPECTIVE
In our large cohort of asymptomatic ethnic Chinese studied across the glycemic spectrum using comprehensive tissue Doppler imaging and deformational mechanics measurements, greater dysglycemia (pre-diabetes mellitus or diabetes mellitus versus normoglycemia, higher individual glycemic indices including insulin resistance, and uncontrolled versus controlled diabetes mellitus) was associated with more adverse cardiac remodeling, left ventricular diastolic dysfunction, and reduction in left ventricular longitudinal systolic function despite preservation of left ventricular ejection fraction. These associations were independent of clinical covariates and similar in lean (body mass index <23 kg/m 2 ) and nonlean individuals. Furthermore, we found that preclinical left ventricular systolic dysfunction was present at low thresholds of glycemic indices (97 versus 106 mg/dL for fasting glucose, 130 versus 135 mg/dL for postprandial glucose, 5.62% versus 6.28% for glycosylated hemoglobin, and 1.81 versus 2.40 for homeostasis model assessment of insulin resistance in lean versus nonlean subjects, respectively). These data demonstrate the presence of preclinical cardiac remodeling and dysfunction in prediabetic and diabetic Chinese adults, occurring at lower thresholds of glycemic indices than defined by international standards particularly in lean individuals. Our data extend the concept of diabetic cardiomyopathy to an earlier stage of dysglycemia, where several detectable functional alterations may precede overt structural changes, and raise the possibility of using deformation imaging as a clinical tool for early detection of preclinical cardiac changes among individuals who may be targeted for preventive therapy.
Lin et al; Systolic Cardiac Mechanics in Dysglycemic Chinese sphygmomanometer-defined resting blood pressures were measured by medical staff members blinded to the other test results. The presence of a history of hypertension was defined as systolic blood pressure >140 mm Hg, diastolic blood pressure > 90 mm Hg, or previously diagnosed hypertension under pharmaceutical control.
Dysglycemia Classification and Insulin Resistance
Among original 4031 study participants with BMI available, 3950 had fasting and postprandial sugar levels, fasting insulin, and diabetes mellitus data available for categorization into 1 of 3 groups: (1) healthy control with no diabetes mellitus (n=1416), no known diabetes mellitus with fasting glucose level <100 mg/mL and glycosylated hemoglobin (HbA1c) <5.7%; (2) pre-diabetes mellitus (n=2029), no known diabetes mellitus before with HbA1c between 5.7% and 6.4% or fasting glucose value 100 to 126 mg/dL; (3) diabetes mellitus (n=505), known diabetes mellitus or on antidiabetic medications. Participants without a prior diagnosis of diabetes mellitus but presenting with HbA1c ≥6.5% or fasting glucose level ≥126 mg/dL were classified as diabetic. Insulin resistance (assessed by using homeostasis model assessment of insulin resistance [HOMA-IR]) was calculated from the formula: HOMA-IR=fasting glucose (mg/dL)×fasting insulin (μU/ mL)/405. 15 We further categorized 505 diabetic subjects as controlled (HbA1c <7%; n=280, 55.4%) and uncontrolled (HbA1c ≥7%; n=225, 44.6%) based on 2017 American Diabetes Association guidelines.
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Measures of Circulating N-Terminal Pro-BType Natriuretic Peptide Level
The concentration of serum biomarker Nt-proBNP (N-terminal pro-B-type natriuretic peptide) was determined by a standard electrochemiluminescence immunoassay (ECLIA assay; Roche Diagnostics GmbH, D-68298 Mannheim). After ensuring individualized patient samples by venipuncture, calibrators and controls were placed at ambient temperature (20-25°C) and were measured within 2 hours.
Echocardiographic Analysis
Each participant underwent comprehensive 2-dimensional, M-mode, and tissue Doppler echocardiography (Vivid i; GE Medical System, Vingmed, Norway, equipped with a 2.5 to 4.5-MHz transducer) from 3 consecutive cardiac cycles. Standard parasternal and apical views were obtained in the left lateral decubitus position. The current analysis focused on parameters of LV structure: mean LV wall thickness, relative wall thickness, LV end-systolic volume, LV end-diastolic volume, and LV mass indexed to height.
3,17 LV end-systolic volume and LV end-diastolic volume were assessed by the biplane Simpson method. We divided LV mass by LV end-diastolic volume to obtain the LV mass-to-volume ratio in terms of concentricity. We characterized LV diastolic function using deceleration time, isovolumic relaxation time, left atrial volume, early mitral inflow peak velocity (E wave), mitral annulus (lateral wall) tissue Doppler systolic (s′) and early diastolic (e′) velocity, and the mitral E/e′ ratio.
Speckle-Tracking Analysis Protocol
LV deformation data were obtained using baseline 2D images from 3 LV apical views (including 2-chamber, 4-chamber, and 3-chamber views) for longitudinal strain; 3 short-axis views (including mitral, papillary, and apical levels) for LV circumferential strain, with LV twist analysis quantified by subtracting rotation from LV mitral annulus (minus in data presentation) to LV apical level (positive in data presentation) as net angle differences as detailed in our previous work. 12 Offline endocardial border manual tracing was performed by the same experienced technician using novel proprietary software (version 10.8, EchoPAC; GE Vingmed Ultrasound, Norway). 12 The mean imaging acquisition frame rate in all participants was 60 to 80 fps. By using automated speckletracking algorithms, LV global longitudinal strain (GLS) was then averaged from the 3 LV apical views, with global circumferential strain (GCS) curves similarly averaged from the 3 short-axis levels. LV torsion was then further calculated as LV torsion=LV twist normalized by apex-to-base distance. Reproducibility analysis of relevant deformation and torsional measures were further detailed in the Materials section of the Data Supplement.
Statistical Analysis
Baseline continuous demographic information were compared across ordinal clinical dysglycemic categories (non-diabetes mellitus, pre-diabetes mellitus, and diabetes mellitus) using linear regression for linear trend test and χ 2 test for trend for binary variables (Table 1) , with Cuzick nonparametric test for trend for skewed continuous variables (eg, estimated glomerular filtration rate, Nt-proBNP, and HOMA-IR). For echocardiography parameters, we present the means for each clinical dysglycemic category (non-diabetes mellitus, pre-diabetes mellitus, and diabetes mellitus). Significance of associations was tested using linear regression for linear trend analysis considering dysglycemic category as an ordinal variable (Table 2) . We also examined the differences of echocardiography parameters between BMI categories (BMI <23 or ≥23 kg/m 2 as lean or nonlean) using unpaired t test and further assessed potential interactions between BMI category and ordinal dysglycemic category with respect to all echocardiography parameters as outcome variables through the use of a single multiplicative interaction term (Table 3) . Interactions were assessed by including a single interaction term between the 2 variables of interest (either binary [BMI] or ordinal category treated as a continuous linear predictor).
We also examined the trend of echocardiography outcome measures (including cardiac structures/functions, speckle tracking-derived GLS/GCS, or torsion) across quintiles of various clinical dysglycemic indices (including fasting and postprandial sugar, insulin, and HOMA-IR) as ordinal variables using linear regressions. Uni-and multivariable linear regression models were also conducted separately to explore the associations among various dysglycemic indices ( We further conducted receiver-operating characteristic curves to determine various optimal cutoffs of glycemic indices (blood sugar, HbA1c, and HOMA-IR) for the identification of systolic dysfunction defined by GLS more impaired than −18.0% (the American Society of Echocardiography/European Association of Echocardiography consensus statement threshold limit for normal GLS, and as used in prior publications on systolic function in diabetes mellitus). 18, 19 Values of P<0.05 were considered statistically significant. No adjustment of type 1 error inflation attributable to multiple testing was made. All analyses were conducted using STATA version 12.0 (Stata Corp LP, College Station, TX).
RESULTS
Clinical and Echocardiographic Characteristics Across the Glycemic Spectrum
Among 3950 participants, diabetes mellitus was present in 12.8% (n=505), pre-diabetes mellitus in 51.4% (n=2029), and normoglycemia in 35.8% (n=1416; Table 1 ). The mean BMI was 24.3±3.5 kg/m 2 . Dysglycemic participants were older, more often male, had larger body size (both BMI and waist circumference), higher blood pressure, more dyslipidemia, worse renal function, and lipid profiles and were more likely to have history of cardiovascular diseases compared with normoglycemic individuals (all P<0.05).
Across the glycemic spectrum (Table 2) , increasing dysglycemia was associated with increasing LV wall thickness, LV diameter, and LV volumes; greater LV total mass; and increased LV mass-to-volume ratio (all trend P <0.001). These structural changes were related to the following functional changes with increasing dysglycemia: more prolonged deceleration time and isovolumic relaxation time, lower mitral inflow E/A ratio, lower myocardial contraction s′, lower relaxation velocity e′ (11.2, 10.3, and 8.8 cm/s), higher E/e′ (6.8, 7.2, and 8.3), and larger left atrial volumes (all trend P <0.001). Cardiac mechanics also correlated with glycemic status, where increasing dysglycemia was associated with more impaired GLS (−20.5%, −20.1%, and −19.0%) accompanied by enhanced torsion (2.17, 2.2, and 2.34°/cm; all trend P<0.05) but similar GCS (Table 2) . These findings were similar after multivariable adjustment (data not shown).
Across quintiles of fasting and postprandial sugar, HbA1c level, and insulin resistance (HOMA-IR), increasing dysglycemia was associated with lower LV e′, higher LV E/e′, worse GLS, and more enhanced torsion (Figure 1 ; Table I in the Data Supplement; all trend P<0.05), even after multivariable adjustment. The independent association of GLS with higher dysglycemic indices (including fasting, postprandial sugar levels, HbA1c and HOMA-IR [adjusted coefficient value: 0.12, 0.04, 0.28, and 0.12, respectively; all P<0.001]) was notable (Figure 2) . Furthermore, a similar trend toward worse GLS and more enhanced torsion were observed across quintiles of various clinical dysglycemic indices and different cutoff values of fasting or postprandial sugar, HbA1c, or HOMA-IR levels (Figures I and II in the Data Supplement; Data are displayed as n (%) and median±SD. E/e′ is the relationship between maximal values of passive mitral inflow (E, pulsed wave-Doppler) and lateral early diastolic mitral annular velocities (e′, tissue Doppler imaging). M/V ratio is mass-to-volume ratio. A indicates late diastolic filling velocity; DT, deceleration time; E, early diastolic filling velocity; GCS, global circumferential strain; GLS, global longitudinal strain; IVRT, isovolumic relaxation time; IVS, interventricular septum; LV, left ventricle; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; RWT, relative wall thickness; and S′, peak systolic annular velocity. *Paired comparisons P<0.05 vs non-diabetes mellitus. †P<0.05 vs pre-diabetes mellitus.
all P<0.05), with no interactions between BMI category (lean versus nonlean) and all glycemic indices. We further assessed the associations of cardiac structure and function with degree of sugar control among diabetic individuals. Among 505 diabetic subjects, 242 had uncontrolled diabetes mellitus (Table II in the Data Supplement). Compared with nondiabetics and well-controlled diabetics, uncontrolled diabetes mellitus was associated with more adverse cardiac remodeling (greater LV wall thickness, LV volumes, and LV mass; all trend P<0.001), along with more impaired diastolic parameters (longer deceleration time, isovolumic relaxation time, lower LV e′, and higher E/e′), markedly reduced GLS, and more pronounced torsional mechanics (all trend P≤0.001). These trends remain unchanged after multivariable adjustment.
Lean Versus Nonlean Participants
We further categorized study participants by body size (lean versus nonlean) and dysglycemic categories (Table   III in the Data Supplement). Compared with nonlean dysglycemic individuals (with pre-diabetes mellitus or diabetes mellitus), lean normoglycemic and dysglycemic individuals were younger, more likely to be female, showed smaller waist (or waist-to-hip ratio), lower blood pressure or prevalent hypertension, more favorable lipid profiles, and better renal function, as well as lower LV wall thickness, smaller LV volumes, lesser degree LV remodeling, better diastolic parameters, and overall slightly better GLS/GCS (Table 3 ; all P<0.05). In both lean and nonlean individuals, increasing dysglycemia was associated with older age, larger body size, higher blood pressure, and trends toward increased LV wall thickness, greater degree of concentric remodeling, higher LV mass, more impaired diastolic indices (deceleration time, isovolumic relaxation time, LV e′, and E/e′), and more impaired GLS (all trend P<0.05). However, torsion was only augmented with increasing dysglycemia in the nonlean groups (trend P=0.002). Of note, lean diabetics had comparable indexed LV mass Data are displayed as n (%) and median±SD. E/e' is the relationship between maximal values of passive mitral inflow (E, pulsed wave-Doppler) and lateral early diastolic mitral annular velocities (e′, tissue Doppler imaging). M/V ratio is mass-to-volume ratio. BMI indicates body mass index; DT, deceleration time; E, early diastolic filling velocity; GCS, global circumferential strain; GLS, global longitudinal strain; IVRT, (Table 3) . We further compared the key cardiac strains and torsional mechanics in 554 subjects with known antihypertensive medications out of 688 hypertensive patients in current work ( Figure III in the Data Supplement). No significant differences were observed in the key cardiac mechanical measures between those medication users and nonusers.
Cutoffs for Glycemic Indices Associated With Preclinical LV Systolic Dysfunction
Using a cutoff of GLS more impaired than −18.0%, 18, 19 the prevalence of subclinical LV systolic dysfunction was 7% among lean dysglycemic individuals (18.1% in lean diabetics) and 15.1% among nonlean dysglycemic individuals (28.8% in nonlean diabetics; Table 3 ). The optimal cutoffs of glycemic indices for identifying subclinical LV systolic dysfunction seemed to be lower in lean compared with nonlean individuals: 97 versus 106 mg/dL for fasting glucose, 130 versus 135 mg/dL for postprandial glucose, 5.62% versus 6.28% for HbA1c and 1.81 versus 2.40 for HOMA-IR in lean and nonlean subjects, respectively.
DISCUSSION
In our large cohort of asymptomatic ethnic Chinese studied across the glycemic spectrum using comprehensive tissue Doppler imaging and deformational mechanics measurements, greater dysglycemia (pre-diabetes mellitus or diabetes mellitus versus normoglycemia, higher individual glycemic indices including HOMA-IR, uncontrolled versus controlled diabetes mellitus) was associated with more adverse cardiac remodeling, LV diastolic dysfunction, and reduction in LV longitudinal systolic function despite preservation of LV ejection fraction. These associations were independent of clinical covariates and similar in lean (BMI <23 kg/m 2 ) and nonlean individuals. Furthermore, we found that preclinical LV systolic dysfunction was present at low thresholds of 97 versus 106 mg/dL for fasting glucose, 130 versus 135 mg/dL for postprandial glucose, 5.62% versus 6.28% for HbA1c, and 1.81 versus 2.40 for HOMA-IR in lean versus nonlean subjects, respectively. These data demonstrate the presence of preclinical cardiac remodeling and dysfunction in prediabetic and diabetic Chinese adults, occurring at lower thresholds of glycemic indices than defined by international standards particularly in lean individuals.
To the best of our knowledge, this is the first and largest study of a Chinese cohort providing compre- hensive data on LV structural and functional characteristics across the glycemic spectrum (Table IV in the  Data Supplement) . 6, [20] [21] [22] [23] Compared with the ARIC study (The Atherosclerosis Risk in Communities Study), which showed 1.0/0.8 differences for septal and lateral wall E/e′ and 0.7% for GLS between diabetic and nondiabetic subjects, we observed much larger differences of E/e′ (2.0/1.5 for septal/lateral) and GLS (1.5%) between these 2 groups in a preclinical stage. Compared with another large Asian population-based epidemiology report, the degree of diastolic dysfunction (septal E/e′; Table IV in the Data Supplement) in diabetic subjects was comparable in our group. 24 Further, the advantage of our current cohort was much larger sample size and provided comprehensive measures of systolic deformational mechanics. Our findings are consistent with previous community-based studies showing that LV mass and wall thickness increased with obesity or worsening dysglycemia, 11, 20, 21, 25 although prior reports were limited to relatively smaller or selected samples in Western populations or lacked comprehensive functional assessment. [22] [23] [24] [26] [27] [28] We further provide data extending the concept of diabetic cardiomyopathy to an earlier stage of dysglycemia, where several detectable functional alterations may precede overt structural changes (eg, chamber dilation). This raises the possibility of using deformation imaging as a clinical tool for early detection of preclinical cardiac changes in stage B HF-individuals at higher risk for overt stage C HF and who may be targeted for preventive therapy. Indeed, accelerated uptitration of renin-angiotensin antagonists and β-blockers to maximum tolerated dosages has been shown to be effective for the primary prevention of cardiac events among diabetic patients, 29 and sodium-glucose cotransporter inhibitors may be beneficial for the prevention of HF in diabetic patients at risk for HF. 30 The trends toward adverse cardiac remodeling and preclinical LV dysfunction with increasing dysglycemia were clearly demonstrated in our Chinese cohort, despite being younger and leaner compared with prior reports. Chinese are known to develop diabetes mellitus at a younger age and lower BMI compared with whites. 9, 27, 28 Earlier failure of β-cell function, higher propensity to store visceral fat, and subsequent lower lean muscle mass may further reduce metabolic capacity in Asians, resulting in dysregulated glucose metabolism at smaller body sizes. 9, [31] [32] [33] [34] [35] [36] Of note, nearly one fifth of lean diabetics demonstrated subclinical impaired systolic function defined as GLS worse than 18% in our current work. 18, 19 Importantly, lean diabetics had just as much LV remodeling and diastolic dysfunction (similarly higher left ventricular mass index and elevated LV E/e′) as nonlean diabetics in our cohort, suggesting the dominant influence of metabolic disturbance rather than mechanical effects of body weight per se on the heart. It has been proposed that augmented torsion may serve to compensate for pathological longitudinal functional decline. 37, 38 Supporting this concept, we observed a consistent trend toward greater torsion across clinical dysglycemic spectrum (from non-diabetes mellitus to pre-diabetes mellitus and diabetes mellitus) and in uncontrolled diabetes mellitus, in parallel with impaired GLS. Our findings are consistent with others. [39] [40] [41] The mechanism of enhanced LV torsion in diabetes mellitus has not been fully elucidated and may relate to changes in the extracellular matrix, which contribute to stored potential energy in the spiraling myofibers of the LV during its twisting motion. 42 Recent studies indicate that Chinese may develop adverse outcomes of diabetes mellitus at lower glucose thresholds compared to internationally defined standards. In a large sample of nearly half a million Chinese adults from the China Kadoorie Biobank, increasing random plasma glucose was related to increased risk of cardiovascular death, major coronary event, and intracerebral hemorrhage, even in the normal range of glucose levels down to 104 mg/dL. 8, 43 Our current work provides evidence of cardiac dysfunction at lower cutoffs of glycemic indices than internationally used to define increased cardiovascular risk, particularly in lean individuals. We postulate that lack of skeletal muscle mass in lean dysglycemic Chinese may be associated with greater disturbances of sugar uptake/metabolism, resulting in dysglycemic cardiotoxic effects (eg, lipotoxicity, oxidative stress) even at sugar levels considered normal by international standards. [44] [45] [46] Limitations of this study include the lack of follow-up for outcome events or reversibility of cardiac abnormalities with improvement of blood glucose level. Nonetheless, this is the largest cross-sectional study of cardiac structural and functional parameters across the entire glycemic spectrum among Chinese adults, with hypothesis-generating results that warrant further mechanistic and outcome studies.
CONCLUSIONS
Dysglycemia and increased insulin resistance are associated with cardiac structural and functional abnormalities along the diabetic continuum, which extends into the early prediabetic and even upper normal range among Chinese adults. Thresholds of glycemic indices at which cardiac dysfunction may be detected are even lower in lean compared with nonlean Chinese individuals. The reversibility of cardiac effects with improved glucose control, and association with future cardiovascular events, deserve further study.
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